Accentia Biopharmaceuticals confirms what Mayo Clinic investigators proposed: that many, if not all, cases of chronic sinusitis have their source in fungal-induced inflammation. The findings are the result of a clinical trial with patients who had well-documented chronic sinusitis based on a history of symptoms, nasal endoscopy, and a CT scan. Of 50 nasal mucin collections, all tested positive for eosinophilic major basic protein (eMBP), which is “a toxic protein released by inflammatory cells in response to fungi.” The researchers believe that these findings suggest a strong correlation between fungal-induced inflammation and chronic sinusitis.
As the Mayo Clinic discovered, the mold Alternaria can be found almost everyone’s nose mucus and sinuses. However, in those with chronic sinusitis, this mold causes eMBP to be released. Eventually, this eMPB causes damage to the mucosal epithelial lining of the nose and sinuses, which in turn leads to the inflammatory mucousal changes indicative of chronic sinusitis.
Using the sinusitis patient treatment protocol can help relieve sinusitis symptoms by treating the cause, fungus (mold).
Chronic sinusitis cases are caused by fungal (mold)-induced inflammation due to the environmental overload almost 100 percent of the time. Therefore, Amphotericin-B, a prescription antifungal is being used in clinical trials to treat chronic sinusitis.
Citrus seed extracts are known for their antifungal properties. Micro Balance CitriDrop Spray, irrigation, and steam are natural options for treating sinusitis.
Go here: http://www.medicalnewstoday.com/articles/82116.php to see the full article in Medical News Today.